Home › Epstein-Barr Virus Infections › Ohio
Epstein-Barr Virus Infections clinical trials in Ohio
5 studies for Epstein-Barr Virus Infections are looking for participants at sites in Ohio.
Cities in Ohio
Donor-Derived Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
RecruitingPhase 1/2
4 Weeks · All sexes · Updated Sep 4, 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
- Akron Children's Hospital, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- The Ohio State University Wexner Medical Center - James Cancer Hospital, Columbus
RecruitingPhase 2
2 Days · All sexes · Updated Sep 4, 2026 · NCT02532452A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Cleveland Clinic Foundation (Adults and Pediatrics), Cleveland
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (Adults and Pediatrics), Columbus
RecruitingPhase 3
All ages · All sexes · Updated Sep 2, 2026 · NCT03394365A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Nationwide Children's Hosptial, Columbus
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266653From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.